Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...

Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...

Today, the United States celebrates the anniversary of its independence from Great Britain.  Independence Day, also known as ...

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...

“Personalizing treatment in this way may lessen harmful side effects, reduce damage to healthy cells and make it more likely ...

A new study reveals that rectal spacers during prostate cancer radiation therapy significantly reduce long-term erectile ...

Discover a study comparing ultrasound and CBCT for bladder monitoring in prostate cancer radiotherapy to improve accuracy and ...

Leading the nation in cancer diagnoses is Maine, which recorded 650 cancer cases per 100,000 residents in 2021—the highest in the U.S. The most common cancer in Maine is breast cancer, followed ...

Merck (NYSE:MRK) recently initiated the IDeate-Prostate01 phase 3 trial, dosing the first patient for its investigational drug ifinatamab deruxtecan, aimed at treating metastatic castration-resistant ...

Breast cancer is the most commonly diagnosed cancer among women worldwide and represents a major public health concern due to ...

Oncologist backs up Irish Cancer Society's grim report about avoidable deaths caused by delays in cancer care 'I see the ...

The reboot of HBO's groundbreaking series 'Sex and the City' has failed to mature the women at the center of the show, or ...